Constellation Spring 2004 Volum olumee 4, Issue 1

First Page		Document Content
Date: 2004-06-03 16:11:42 Clinical trials Endocrinology Phenols Piperidines Study of Tamoxifen and Raloxifene Tamoxifen Raloxifene Breast cancer Aromatase inhibitor Medicine Chemistry Selective estrogen receptor modulators		Constellation Spring 2004 Volum olumee 4, Issue 1 Add to Reading List Source URL: www.nsabp.pitt.edu Download Document from Source Website File Size: 732,92 KB Share Document on Facebook

	Drug Facts: NOLVADEX (tamoxifen) W hat is this drug for? Reduce the chance of getting breast cancer W ho m ight consider taking it? Women at high risk of getting breast cancer (1.7% or DocID: Yj9a - View Document
	Sample Tool: Values (Tamoxifen) D. The things that are important to me when making a decision about tamoxifen Below are listed some things women consider when deciding about taking tamoxifen to lower their risk of breast DocID: XUIt - View Document
	Insurance Coverage_ California - National Cancer Institute DocID: R3MF - View Document
	Microsoft PowerPoint - Kramer.ppt [Compatibility Mode] DocID: DyGD - View Document
	Microsoft Word - last final benigh breast disease release.doc DocID: ynbo - View Document